Royal Bank of Canada’s Oramed Pharmaceuticals ORMP Stock Holding History

Royal Bank of Canada’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1K	Buy	+174	New	+$590	﹤0.01%	6921
2025 Q4	–	Sell	-3,483	Closed	-$9K	–	7492
2025 Q3	$9K	Sell	3,483 -44,108	-93%	-$97.5K	﹤0.01%	6534
2025 Q2	$107K	Sell	47,591 -39,397	-45%	-$86.9K	﹤0.01%	5578
2025 Q1	$186K	Buy	86,988 +1,463	+2%	+$3.38K	﹤0.01%	4750
2024 Q4	$207K	Buy	85,525 +81,298	+1,923%	+$193K	﹤0.01%	4792
2024 Q3	$10K	Sell	4,227 -854	-17%	-$2.08K	﹤0.01%	6336
2024 Q2	$13K	Buy	+5,081	New	+$12.1K	﹤0.01%	6248
2024 Q1	–	Sell	-9,244	Closed	-$21K	–	7432
2023 Q4	$21K	Buy	9,244 +3,971	+75%	+$8.48K	﹤0.01%	6297
2023 Q3	$14K	Buy	+5,273	New	+$16.6K	﹤0.01%	6316
2023 Q2	–	Sell	-10,000	Closed	-$22K	–	7538
2023 Q1	$22K	Sell	10,000 -2,000	-17%	-$6.35K	﹤0.01%	5997
2022 Q4	$144K	Sell	12,000 -11,977	-50%	-$93.1K	﹤0.01%	5170
2022 Q3	$155K	Buy	23,977 +735	+3%	+$5.95K	﹤0.01%	4972
2022 Q2	$106K	Buy	23,242 +7,650	+49%	+$40.9K	﹤0.01%	5293
2022 Q1	$135K	Sell	15,592 -3,713	-19%	-$38K	﹤0.01%	5419
2021 Q4	$276K	Buy	19,305 +4,379	+29%	+$91.5K	﹤0.01%	5018
2021 Q3	$328K	Buy	14,926 +11,092	+289%	+$189K	﹤0.01%	4710
2021 Q2	$51K	Buy	3,834 +1,834	+92%	+$21K	﹤0.01%	6023
2021 Q1	$20K	Sell	2,000 -2,500	-56%	-$20.5K	﹤0.01%	6428
2020 Q4	$19K	Buy	4,500 +1,000	+29%	+$3.25K	﹤0.01%	6090
2020 Q3	$9K	Sell	3,500 -1,198	-26%	-$4.17K	﹤0.01%	5959
2020 Q2	$17K	Hold	4,698	–	–	﹤0.01%	5653
2020 Q1	$15K	Buy	4,698 +198	+4%	+$868	﹤0.01%	5675
2019 Q4	$24K	Sell	4,500 -383	-8%	-$1.44K	﹤0.01%	5782
2019 Q3	$16K	Buy	4,883 +3,383	+226%	+$11.3K	﹤0.01%	5600
2019 Q2	$6K	Hold	1,500	–	–	﹤0.01%	6241
2019 Q1	$6K	Hold	1,500	–	–	﹤0.01%	6208
2018 Q4	$5K	Sell	1,500 -24	-2%	-$99	﹤0.01%	6165
2018 Q3	$7K	Buy	1,524 +24	+2%	+$125	﹤0.01%	6121
2018 Q2	$11K	Hold	1,500	–	–	﹤0.01%	5788
2018 Q1	$10K	Hold	1,500	–	–	﹤0.01%	5718
2017 Q4	$14K	Buy	1,500 +1,000	+200%	+$9.56K	﹤0.01%	5747
2017 Q3	$5K	Hold	500	–	–	﹤0.01%	6425
2017 Q2	$4K	Hold	500	–	–	﹤0.01%	6119
2017 Q1	$3K	Hold	500	–	–	﹤0.01%	6358
2016 Q4	$3K	Hold	500	–	–	﹤0.01%	6419
2016 Q3	$4K	Hold	500	–	–	﹤0.01%	6034
2016 Q2	$4K	Hold	500	–	–	﹤0.01%	6013
2016 Q1	$3K	Sell	500 -200	-29%	-$1.34K	﹤0.01%	6053
2015 Q4	$6K	Buy	700 +500	+250%	+$3.79K	﹤0.01%	6105
2015 Q3	$1K	Hold	200	–	–	﹤0.01%	6500
2015 Q2	$1K	Hold	200	–	–	﹤0.01%	6459
2015 Q1	$1K	Sell	200 -6,389	-97%	-$30.9K	﹤0.01%	5988
2014 Q4	$30K	Buy	6,589 +6,489	+6,489%	+$42.7K	﹤0.01%	5254
2014 Q3	$1K	Hold	100	–	–	﹤0.01%	5875
2014 Q2	$1K	Hold	100	–	–	﹤0.01%	5825
2014 Q1	$1K	Sell	100 -100	-50%	-$1.69K	﹤0.01%	5809
2013 Q4	$3K	Hold	200	–	–	﹤0.01%	5706
2013 Q3	$1K	Hold	200	–	–	﹤0.01%	5965
2013 Q2	$2K	Buy	+200	New	+$1.65K	﹤0.01%	5625

Other funds holding ORMP

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada's ORMP Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in Oramed Pharmaceuticals (ORMP) in Q1 2026: 174 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #6921 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in ORMP as recently as Q3 2025.

Royal Bank of Canada first reported a position in ORMP in Q2 2013 and has held it in 49 quarters since. The position peaked at $328K in Q3 2021. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

Royal Bank of Canada held 174 shares of Oramed Pharmaceuticals worth $1K as of Q1 2026.
Oramed Pharmaceuticals was a new Royal Bank of Canada position in Q1 2026.
Oramed Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6921 holding.
Royal Bank of Canada first reported a position in Oramed Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
Royal Bank of Canada's Oramed Pharmaceuticals position peaked at $328K in Q3 2021.
64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.